News
The Health Care Select Sector SPDR Fund ETF (NYSEARCA:XLV), which tracks the health care sector, and holds a weightage of ...
22h
Zacks Investment Research on MSNIs UnitedHealth (UNH) a Buy as Wall Street Analysts Look Optimistic?The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
23h
Zacks Investment Research on MSNUnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should KnowUnitedHealth Group (UNH) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...
The Justice Department is investigating UnitedHealth’s Medicare billing practices, focusing on diagnosis coding and doctor ...
Detailed price information for Hca Holdings Inc (HCA-N) from The Globe and Mail including charting and trades.
Ultragenyx and partner Mereo BioPharma’s brittle bone disease trial will continue. Investors had wanted data good enough to ...
Ultragenyx Pharmaceutical Inc. shares plunged 30% as UX143 trial raises efficacy doubts. Click for more on RARE and my ...
Complete UnitedHealth Group Inc. stock information by Barron's. View real-time UNH stock price and news, along with industry-best analysis.
Insights from CNBC's Halftime Report Final Trades on industrial, healthcare sectors and e-commerce potential, with stock ...
Key Takeaways: 2025 offers new opportunities in tech, energy, and finance sectors.Long-term investors may benefit from stable and high-growth companies.Market r ...
Detailed price information for Elevance Health Inc (ELV-N) from The Globe and Mail including charting and trades.
UnitedHealth Group is preparing to report its Q2 2025 earnings, with analysts predicting a drop in earnings per share (EPS) to $5.08. The company’s stock has underperformed significantly over the last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results